Liquid-Based Cytology Advancements and p16/Ki-67 Dual-Stain Triage Innovations

Rising clinical adoption of automated liquid-based cytology (LBC) slides, integration of p16/Ki-67 dual-stain immunocytochemistry, and reducing unsatisfactory sample rates are driving technology shifts in the Hpv Testing And Pap Test Market. LBC preserves cervical cells in liquid fixative vials, enabling automated thin-layer slide preparation and allowing both Pap cytology and reflex hrHPV molecular testing from a single sample vial.

In addition, implementing p16/Ki-67 dual-stain immunocytochemistry improves triage accuracy for hrHPV-positive women. Dual-staining identifies deregulated cell cycle control, accurately distinguishing true transforming precancerous lesions from transient, non-transforming HPV infections.

Beyond cervical screening, LBC vials facilitate reflex molecular testing for sexually transmitted co-infections, including Chlamydia trachomatis and Neisseria gonorrhoeae.

Furthermore, enterprise pathology LIMS platforms track liquid-based vial inventory and automated slide preparation logs, ensuring laboratory quality assurance.

Advanced liquid-based cytology and dual-stain immunocytochemistry optimize cervical cancer risk stratification and prevent unnecessary colposcopy referrals.

Will p16/Ki-67 dual-stain immunocytochemistry completely replace standalone Pap cytology reflex testing for hrHPV-positive triage by 2030?

People Also Ask How does Liquid-Based Cytology (LBC) improve over conventional Pap smears? LBC transfers cervical cells into a liquid preservative, removing blood and mucus interference, producing uniform thin-layer slides, and preserving extra fluid for reflex HPV DNA testing.

What does a positive p16/Ki-67 dual-stain result indicate in cervical screening? Dual-stain positivity confirms that a cervical cell expresses both a tumor suppressor marker (p16) and a cell proliferation marker (Ki-67) simultaneously, signaling active oncogenic cell transformation.

#HpvTestingAndPapTestMarket #LiquidBasedCytology #DualStain #PathologyInnovation #MarketResearchFuture

Leia Mais